BLOG

New York, December 21, 2023 – Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct a phase 1/2 clinical trial using the company’s innovative StemSpine® treatment

New York, December 21, 2023 – In two weeks, 2023 will be history so consider this your reminder to start figuring out a resolution that